Cargando…
Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209944/ https://www.ncbi.nlm.nih.gov/pubmed/35747832 http://dx.doi.org/10.3389/fonc.2022.952053 |
| _version_ | 1784730056521678848 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9209944 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92099442022-06-22 Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial Front Oncol Oncology Frontiers Media S.A. 2022-06-07 /pmc/articles/PMC9209944/ /pubmed/35747832 http://dx.doi.org/10.3389/fonc.2022.952053 Text en Copyright © 2022 Frontiers Production Office https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title | Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_full | Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_fullStr | Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_full_unstemmed | Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_short | Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_sort | erratum: corrigendum: efficacy and safety of tumor treating fields (ttfields) in elderly patients with newly diagnosed glioblastoma: subgroup analysis of the phase 3 ef-14 clinical trial |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209944/ https://www.ncbi.nlm.nih.gov/pubmed/35747832 http://dx.doi.org/10.3389/fonc.2022.952053 |
| work_keys_str_mv | AT erratumcorrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial |